Bain Capital Life Sciences

General contacts
Investor type

PE / VC / Fund of funds

Founded

2016

AUM

$6 300 M

Location

Boston, Massachusetts, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Series A Seed Late Stage (Series C+)

Region of investment

Europe North America Asia
Investor profile last updated: 16 August, 2026

Profile

Bain Capital Life Sciences is a venture capital firm based in Boston, Massachusetts, founded in 2016. The firm is part of Bain Capital, a global private investment firm. Bain Capital Life Sciences has a team of 20 professionals, including 7 partners, who leverage their deep industry expertise and clinical insights to drive innovation in the life sciences sector.

The firm focuses on investments in pharmaceuticals, biotechnology, medical devices, diagnostics, and life science tools. Bain Capital Life Sciences typically invests in growth capital and turnaround opportunities, with a particular emphasis on the United States market. The firm manages several funds, including Bain Capital Life Sciences Fund II with $975 million in assets under management, and Bain Capital Life Sciences Fund IV with $3 billion.

Notable investments by Bain Capital Life Sciences include X4 Pharmaceuticals - a biopharmaceutical company, SpringWorks Therapeutics - a clinical-stage biopharmaceutical company, and C4 Therapeutics - a biotechnology company. These investments highlight the firm's commitment to advancing life sciences innovation.

Industry

HealthTech Life Sciences Pharmaceuticals Medical Devices Biotechnology Healthcare Services Media and Entertainment

Bain Capital Life Sciences Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region 		Size AUM Launch date
Bain Capital Life Sciences Fund II
Fund of funds
Healthcare Services
Media and Entertainment
HealthTech
Seed
Series A
Series B
North America
Europe
$5-10 m
$975 M
December 2018
Bain Capital Life Sciences Fund IV
Fund of funds
Healthcare Services
Media and Entertainment
HealthTech
Seed
Series A
Series B
North America
Europe
$5-10 m
$3000 M
September 2024

Contacts

Name
Title
Email
Social Networks
avatar
Melaku Arega, MD Vice President
Vice President
m•••@•••
avatar
Nicholas Downing Partner
Partner
n•••@•••
Upgrade to see contacts
avatar
jDXscwyfLSnqizFa jDXscwyfLSnqizFa
jDXscwyfLSnqizFa
[email protected]
linkedin twitter
avatar
jDXscwyfLSnqizFa jDXscwyfLSnqizFa
jDXscwyfLSnqizFa
[email protected]
linkedin twitter
avatar
jDXscwyfLSnqizFa jDXscwyfLSnqizFa
jDXscwyfLSnqizFa
[email protected]
linkedin twitter
Investment-team contacts for Bain Capital Life Sciences — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Bain Capital Life Sciences

Bain Capital Life Sciences is a venture capital and private equity firm that also operates as a fund of funds. It backs companies at Series B, Series A, Seed and Late Stage (Series C+), writing tickets of $10-50 m.
Bain Capital Life Sciences is located in Boston, Massachusetts, United States.
Bain Capital Life Sciences was founded in 2016.
Bain Capital Life Sciences invests in companies and startups in HealthTech, Life Sciences, Pharmaceuticals, Medical Devices, Biotechnology, Healthcare Services, Media and Entertainment.
Bain Capital Life Sciences invests in companies and startups in Europe, North America, Asia.
Bain Capital Life Sciences invests in companies and startups at Series B, Series A, Seed, Late Stage (Series C+).
Bain Capital Life Sciences usually invests $10-50 m on average.
Bain Capital Life Sciences has around $6 300m assets under management.
Bain Capital Life Sciences last fund was created/launched in 2024-09-10
Bain Capital Life Sciences can be reached through its website baincapitallifesciences.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Bain Capital Life Sciences — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Bain Capital Life Sciences directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.